RT Journal Article
SR Electronic
T1 Epidemiology of cruciate ligament surgery in Japan: A retrospective cohort study from 2014 to 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.06.23292305
DO 10.1101/2023.07.06.23292305
A1 Uchino, Shota
A1 Taguri, Masataka
YR 2023
UL http://medrxiv.org/content/early/2023/07/07/2023.07.06.23292305.abstract
AB Understanding the incidence and trends of cruciate ligament (CL) surgeries in Japan is crucial for providing effective healthcare services. This study aimed to use open data available from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) to determine the changes over time in CL surgeries and to analyze the characteristics of the Japanese population in terms of sex and age. We retrospectively identified CL surgeries of the knee joint registered from April 2014 to March 2020 using the NDB open data. Data on sex, age, and practice were extracted to determine the number of cases per 100,000 population. Trends in the annual incidence of CL surgeries were evaluated using Poisson regression analysis. In total, 112,686 CL surgeries were performed from 2014 to 2019. Arthroscopic ligament reconstruction accounted for 98% of all the cases. The number of surgeries performed had increased significantly from 16,975 in 2014 to 19,735 in 2019 (P<0.001). Overall, CL surgeries were most common in the 15–19 years age group, followed by the 20–29 years age group. However, these trends differed between males and females. The incidence of CL surgery in Japan has increased, and its characteristics vary by gender and age. These characteristics have been identified not only in younger patients but also in middle-aged and older patients. It would be valuable to further investigate the general patterns of CL surgery in Japan.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The NDB open data is widely available for research purposes by the Ministry of Health, Labour, and Welfare (MHLW). The data is compiled and published based on existing anonymized NDB, and since there is no corresponding table, individuals cannot be identified. Therefore, ethical approval was not required for this study. NDB opendata https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177182.htmlI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe utilized the NDB Open Data managed by the Ministry of Health, Labour and Welfare. Access to the dataset can be obtained through the website of the Ministry of Health, Labour and Welfare at [https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177182.html].https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177182.html